scorecardresearch
Add as a preferred source on Google
Thursday, December 4, 2025
TopicDr Reddy's

Topic: Dr Reddy's

Using ‘4IR’ tech to beat global challenges — why 4 Indian firms are on WEF’s ‘lighthouses’ list

Cipla, Dr Reddy’s Lab, Mondelez & Unilever lauded for transition to fourth industrial revolution using advanced technologies despite global challenges like Ukraine war & Covid.

Dr. Reddy’s gets emergency use approval from DCGI for Russian vaccine Sputnik Light

Sputnik Light is second Covid vaccine to be made available in India by Dr. Reddy’s. In April 2021, DCGI granted approval to two-dose Sputnik V vaccine for restricted use in India.

Haryana’s tech-based healthcare approach could be a blueprint for our response to Covid-19

A project piloted by Deloitte and the Haryana govt in Karnal district resulted in a significant reduction in the number of fatalities from Covid-19.

Full launch of Sputnik V vaccine in India could take more time, says Dr Reddy’s

Dr Reddy's, through which Russia's Sputnik V is available in India, said the timeline was pushed a little further due to import dependency, quality checks.

Dr Reddy’s announces commercial launch of Covid drug 2-DG, to cost Rs 990/sachet

The drug was developed by DRDO in collaboration with Dr Reddy's and granted emergency use approval on 1 May. It will be supplied to major govt and private hospitals across India.

Not authorised any third party to supply Sputnik V, sole distributor in India: Dr Reddy’s

Dr Reddy's urged everyone to beware of unauthorised individuals offering fake deals or procurement of the Sputnik V vaccine and has has initiated legal action against any entities.

Second batch of Sputnik V vaccine containing 60,000 doses arrives in Hyderabad

Dr Reddy's Laboratories on 14 May soft-launched the Russian Covid vaccine, priced at Rs 948, with 5% GST per dose. The first consignment 1.50 lakh doses had landed on 1 May.

Govt panel rejects emergency-use approval for Dr Reddy’s Russian-origin potential Covid drug

The company had requested for waiver of clinical trials in India as a condition to market the monoclonal, antibody-based drug, Olokizumab.

First batch of Sputnik V vaccine to reach Kanpur medical college for Phase 2, 3 trials

According to officials, the decision to conduct the human clinical trials was taken after Dr Reddy's Laboratories got approval from the Drugs Controller General of India.

Modi govt panel rejects emergency-use approval for Dr Reddy’s potential Covid drug

Originally intended for cancer, Dr Reddy’s 2-DG works by preventing the supply of glucose molecules to cancerous cells, which need glucose for survival. 

On Camera

India’s Russian oil imports are showing up in cryptic new places. The crude map stands redrawn

December oil imports from Russia may drop nearly 50%, but Indian buyers already shifting to non-designated Russian entities and opaque trading channels to keep Russian oil flowing.

From nuclear cooperation to defence, trade to oil, what is expected from Putin’s two-day India visit

New Delhi is interested in firming up bilateral agreements for increased trade, mobility, upgrade of Su-30 MKI fighters and the increased range of BrahMos supersonic missiles.

Gaali cricket: Bavuma stands tall, India’s Test ego cut to size

The India-South Africa series-defining fact is the catastrophic decline of Indian red ball cricket where a visiting team can mock us with the 'grovel' word.